The FDA approved Enhertu for presurgical HER2+ breast cancer treatment. Dr. Shanu Modi discusses the "win-win" for patient efficacy and safety.
Alex Biese is an Assistant Managing Editor at the USA TODAY NETWORK New Jersey and the Asbury Park Press. With a focus on medicine and healthcare, Alex covers a range of topics including oncology, hematology, and public health, while also addressing mental health and patient care. His work has been featured in various prominent outlets, including USA TODAY and the Chicago Sun-Times.













